A postdoctoral research position at Hannover Medical School (HMS), Department of Pediatric Cardiology and Critical Care, is available to study the molecular mechanisms of pulmonary vascular disease and right heart failure, and related translational therapeutic interventions, including cell (iPS cells, mesenchymal stem and progenitor cells), RNA (miR/anti-miR, synthetic modified RNA) and pharmacological approaches.
Requirements: Candidates should be highly motivated and focused, must hold a Ph.D. or M.D./Ph.D. degree in cell/molecular biology or related field, have one or more first author original research publication, the ability to hold deadlines, the willingness to teach students and technicians, and very good English language skills.
Qualifications: Experience and expertise in mammalian cell culture (e.g., proliferation/apoptosis), cloning, biochemical and molecular biology techniques (including qPCR, cloning, lentiviral transduction/shRNAi and/or CRISPR/Cas9 in mammalian cells), siRNA, Western blotting, IP, as well as basics in rodent models is required. Experience with stem cell isolation and differentiation/ iPS cells is highly desired. Experience with airway drug delivery, miR profiling, isolation and culture of primary SMCs, cardiomyocytes, and/or endothelial cells, ChIP, immunohistochemistry, histological quantitative heart-lung tissue analysis, and hemodynamic measurements is desired but not mandatory.
Hannover Medical School (HMS) belongs to the top 3 lung transplantation centers worldwide. Several program project grants at HMS are on heart-lung research. We offer a team oriented environment with a structured mentoring/professional development program and a brand new research facility. Our DFG- and BMBF-funded research group has strong connections to Hannover Biomedical Research School, the DFG Clinical Research Group “(Pre-) terminal heart and lung failure – unloading and repair” (KFO 311; https://www.mhh.de/en/kfo311), and the Fraunhofer Institute ITEM. Salary will be based on the candidate’s level of experience and higher than NIH level. Benefits are excellent. Hannover is centrally located between Hamburg and Berlin and combines a broad cultural and recreational program with moderate costs of living.
Start date of the above position January 1, 2022, or earlier. Applications will be considered for interview until the position is filled.
Disabled candidates with equivalent qualifications will receive preferential consideration. Hannover Medical School is an equal opportunity employer and encourages female/male/diverse scientists to apply. Please submit your application materials including CV, publication list, 1/2-page personal statement (interests/research experience) and three reference letters to:
Prof. Dr. Georg Hansmann, MD, PhD, FESC, FAHA (Principal Investigator)